BVS
Bioventus Inc.
NASDAQ · Healthcare · Medical - Devices · US
$12.72
−3.38%Price chart
Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15
Key dataSep 15, 2026
Open$13.05
From 52W high−16.68%
Volume59286.00
Market cap$868.51M
P/E (TTM)15.8x
P/S (TTM)1.5x
Div yield—
Key dataSep 15, 2026
Open
$13.05
From 52W high
−16.68%
Volume
59286.00
Market cap
$868.51M
ValuationView details →
P/E (Fwd)
15.9x
EV/EBITDA
12.4x
P/E (TTM)
15.8x
RSI (14)
44.1
MomentumView details →
1D Return
−3.38%
YTD Return
+76.95%
SummaryUpdated Jun 1, 2026
Bioventus Inc. (NASDAQ:BVS) is a medical device company founded in 2011 and headquartered in Durham, North Carolina. The company went public in February 2021 and focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing processes. Bioventus serves physicians across the orthopedic continuum in various settings including physician offices, ambulatory surgical centers, and hospitals. The company has experienced significant operational challenges in recent years but has been working to stabilize its business and return to profitable growth through strategic divestitures and operational improvements.
Similar companies
Latest newsMore news →